Yehyung KIM - Kim & Chang

Bio

Yehyung Kim is an attorney at Kim & Chang. Since joining the firm in 2013, Ms. Kim has accumulated experience and expertise in antitrust and fair trade law, corporate investigations and white-collar crimes. In terms of industry expertise, she has provided legal advice to various multinational companies in the healthcare and defense industries.

More recently, she has been focusing on antitrust and fair trade law cases, representing clients from various industries, including healthcare, aviation, ICT, and energy. She frequently deals with investigations by the Korea Fair Trade Commission (the “KFTC”) on cartel, abuse of market dominance, unfair trade practice and false advertising cases. She also has a wide breadth of experience in global and Korean merger filings.

She has successfully handled some of the firm’s most complex cases, which involved various stakeholders and legal/public relations issues. Ms. Kim helps her clients navigate their way through crises and manage business risks to achieve the best outcome possible.

View All

Profile

Experience

Kim & Chang (2013-Present)

Representative Mattersshow

Antitrust & Competition

Represented a full-service carrier as global merger filing counsel in relation to its acquisition of shares in another full-service carrier.
Represented an ice cream manufacturer to appeal the KFTC’s decision on price collusion.
Represented an online platform service provider to appeal the KFTC’s decision regarding alleged discriminatory treatment.
Represented a global investment organization as a merger filing counsel in relation to its acquisition of a Korean security company.
Represented a Korean energy company as its global merger filing counsel in relation to its proposed establishment of a joint venture with an auto-manufacturer.
Represented a global OTA in connection with a KFTC investigation into the company’s alleged violation of the advertisement regulations.
Represented a global OTA in connection with a KFTC investigation into the company’s most favored nation agreement.
Represented a US biotech product development company on its global merger filing.
Represented a French multinational rail transport company on its global merger filing.
Represented multinational companies on their global and local merger filings.
Represented a French cable and optical fiber company in relation to the KFTC’s cartel investigation.
Represented a US engine manufacturer in relation to the KFTC’s investigation.
Represented a Swiss multinational pharmaceutical company in relation to the KFTC’s investigation.

Criminal Investigation & White-Collar Crime

Represented a logistics company in a criminal investigation on the alleged violation of the Occupational Health and Safety Act for mass infection of COVID-19 within the company site.
Represented a multinational consumer goods company based in the UK and its Korean affiliate in a large-scale criminal investigation on fraud (false labelling) allegations.
Represented a major global automotive manufacturer and its affiliate in Korea in a criminal investigation on fraud allegations.
Represented a multinational consumer goods company in relation to its crisis management involving product liability.
Represented a multinational automobile company in relation to its crisis management involving product liability.
Represented a multinational automobile company in relation to its internal investigation involving employee fraud.
Represented a luxury company in relation to its internal investigation and related criminal/HR/civil actions.
Represented various multinational companies in relation to their internal investigations involving employee embezzlement, fraud or harassment.

Healthcare

Represented a major multinational pharmaceutical company in its contract negotiation with a government regarding the supply of COVID-19 vaccines.
Represented multinational pharmaceutical and medical device companies in relation to the regulatory framework in Korea, internal/external compliance, due diligence and audits.
Represented multinational pharmaceutical companies in relation to the Korean National Assembly’s audit.
Represented multinational pharmaceutical and medical device companies on providing employee compliance trainings.